Research Article
BibTex RIS Cite
Year 2023, , 184 - 191, 28.03.2023
https://doi.org/10.33808/clinexphealthsci.1185236

Abstract

References

  • World Health Organization, Global Health Estimates, Leading Causes of Death and Disability, A Visual Summary of Global and Regional Trends 2000-2019. Accessed [19 March 2022]. https://www.who.int/data/stories/leading-causes-of-death-and-disability-2000-2019-a-visual-summary
  • The Lancet Infographics Global Burden of Disease 2019. Accessed [30 September 2021]. https://www.thelancet.com/infographics/gbd-2019
  • World Health Organization. Global Status Report on Noncommunicable Diseases 2014. Accessed [2 February 2020]. https://www.who.int/publications/i/item/9789241564854
  • World Health Organization. Traditional, Complementary and Integrative Medicine. Overview. Accessed [2 February 2020]. https://www.who.int/health-topics/traditional-complementary-and-integrative-medicine#tab=tab_1
  • World Health Organization. WHO Traditional Medicine Strategy: 2014-2023. Accessed [3 February 2020]. https://www.who.int/publications/i/item/9789241506096
  • Burton A, Smith M, Falkenberg T. Building WHO's Global strategy for traditional medicine. Eur J Integr Med. 2015;7(1):13-5. DOI: 10.1016/j.eujim.2014.12.007
  • Mevzuat Bilgi Sistemi. Geleneksel ve Tamamlayıcı Tıp Uygulamaları Yönetmeliği. Accessed [6 February 2020]. https://www.mevzuat.gov.tr/mevzuat?MevzuatNo=20164&MevzuatTur=7&MevzuatTertip=5
  • Ung COL, Harnett J, Hu H. Community pharmacist's responsibilities with regards to traditional medicine/complementary medicine products: A systematic literature review. Res Social Adm Pharm. 2017;13(4):686-716. DOI: 10.1016/j.sapharm.2016.08.001
  • Wode K, Henriksson R, Sharp L, Stoltenberg A, Hök Nordberg J. Cancer patients’ use of complementary and alternative medicine in Sweden: A cross-sectional study. BMC Complement Altern Med. 2019;19(1):1-11. DOI: 10.1186/s12906-019-2452-5
  • Foley H, Steel A, McIntyre E, Harnett J, Sibbritt D, Wardle J, Adams J. Complementary medicine practitioner consultations amongst 1,314 individuals with chronic conditions: Characteristics of users, reasons for and predictors of use. Complement Ther Clin Pract. 2020;40:101194. DOI: 10.1016/j.ctcp.2020.101194
  • Gyasi R, Buor D, Adu-Gyamfi S, Adjei PO-W, Amoah PA. Sociocultural hegemony, gendered identity, and use of traditional and complementary medicine in Ghana. Women Health 2018;58(5):598-615. DOI: 10.1080/03630242.2017.1321608
  • Türkiye İstatistik Kurumu, Adrese Dayalı Nüfus Kayıt Sistemi Sonuçları, Adrese Dayalı Nüfus Kayıt Sistemi İstatistikleri. Accessed [1 May 2020]. http://tuik.gov.tr/PreTablo.do?alt_id=1059
  • T.C. Sağlık Bakanlığı Eskişehir İl Sağlık Müdürlüğü, Aile Sağlığı Merkezleri, Hastaneler. Accessed [1 May 2020]. https://eskisehirism.saglik.gov.tr/TR,39889/aile-sagligi-merkezleri.html
  • Daye M, Durmaz K, Durduran Y. Traditional and complementary medicine practices in patients admitted to dermatology outpatient clinic. Konuralp Medical Journal 2020;12(2):247-252. DOI: 10.18521/ktd.639063
  • Yıldız P, Fatih Ü, Balbay EG. Kronik obstrüktif akciğer hastalarında geleneksel ve tamamlayıcı tıp yöntemi kullanımının değerlendirilmesi. Online Turkish Journal of Health Sciences 2020;5(1):147-54. DOI: 10.26453/otjhs.638683
  • T.C. Resmi Gazete, Sağlık Bakanlığı Geleneksel Ve Tamamlayıcı Tıp Uygulamaları Yönetmeliği. Accessed [16 August 2020]. https://www.resmigazete.gov.tr/eskiler/2014/10/20141027.pdf
  • Lam CS, Koon HK, Chung VCH, Cheung YT. A Public survey of traditional, complementary and integrative medicine use during the COVID-19 outbreak in Hong Kong. PloS One 2021;16(7): 1-15. DOI: 10.1371/journal.pone.0253890
  • Kearns K, Dee A, Fitzgerald AP, Doherty E, Perry IJ. Chronic disease burden associated with overweight and obesity in Ireland: The effects of a small BMI reduction at population level. BMC Public Health 2014;14(1):1-10. DOI: 10.1186/1471-2458-14-143
  • Shahjalal M, Chakma SK, Ahmed T, Yasmin I, Mahumud RA, Hossain A. Prevalence and determinants of using complementary and alternative medicine for the treatment of chronic illnesses: A multicenter study in Bangladesh. PLoS One 2022;17(1): 1-13 DOI: 10.1371/journal.pone.0262221.
  • Bhalerao MS, Bolshete PM, Swar BD, Bangera TA, Kolhe VR, Tambe MJ, Wade MP, Bhowate SD, Sonje UB, Gogtay NJ, Thatte UM. Use of and satisfaction with complementary and alternative medicine in four chronic diseases: A Cross-sectional study from India. Natl Med J India 2013;26(2):75-77.
  • Osamor PE, Owumi BE. Complementary and alternative medicine in the management of hypertension in an urban Nigerian community. BMC Complement Altern Med 2010;10(1):1-9. DOI: 10.1186/1472-6882-10-36
  • Ogbera AO, Dada O, Adeleye F, Jewo PI. Complementary and alternative medicine use in diabetes mellitus. West Afr J Med. 2010;29(3):158-162 DOI: 10.4314/wajm.v29i3.68213
  • Radwan H, Hasan H, Hamadeh R, Hashim M, AbdulWahid Z, Hassanzadeh Gerashi M, Al Hilali M, Naja F. Complementary and alternative medicine use among patients with type 2 diabetes living in the United Arab Emirates. BMC Complement Med Ther. 2020;20(1):216. DOI: 10.1186/s12906-020-03011-5.
  • Judson PL, Abdallah R, Xiong Y, Ebbert J, Lancaster JM. Complementary and alternative medicine use in individuals presenting for care at a comprehensive cancer center. Integr Cancer Ther. 2017;16(1):96-103. DOI: 10.1177/1534735416660384
  • Armstrong AR, Thiébaut SP, Brown LJ, Nepal B. Australian adults use complementary and alternative medicine in the treatment of chronic illness: A national study. Aust N Z J Public Health 2011;35(4):384-390. DOI: 10.1111/j.1753-6405.2011.00745.x
  • Raja R, Kumar V, Khan MA, Sayeed KA, Hussain SZM, Rizwan A. Knowledge, attitude, and practices of complementary and alternative medication usage in patients of type II diabetes mellitus. Cureus 2019;11(8):e5357 DOI: 10.7759/cureus.5357
  • Al-Eidi S, Tayel S, Al-Slail F, Qureshi NA, Sohaibani I, Khalil M, Al-Bedah AM. Knowledge, attitude, and practices of patients with type II diabetes mellitus towards complementary and alternative medicine. J Integr Med. 2016;14(3):187-196. DOI: 10.1016/S2095-4964(16)60244-3
  • Mollaoğlu M, Aciyurt A. Use of complementary and alternative medicine among Patients with Chronic Diseases. Acta Clin Croat. 2013;52(2.):181-188.
  • Hasan SS, Ahmed SI, Bukhari NI, Loon WCW. Use of complementary and alternative medicine among patients with chronic diseases at outpatient clinics. Complement Ther Clin Pract. 2009;15(3):152-157. DOI: 10.1016/j.ctcp.2009.02.003
  • Demirci GT, Altunay IK. Use of complementary and alternative medicine and assessment of dermatology quality of life index among dermatology outpatients: A cross-sectional comparative study. Br J Med Med Res. 2014;4(9):1812-1820 DOI: 10.9734/BJMMR/2014/6924
  • Ee C, Templeman K, Grant S, Avard N, de Manincor M, Reath J, Hunter J. Informing the model of care for an academic integrative health care center: A qualitative study of primary care stakeholder views. J Altern Complement Med. 2020;26(4):300-315. DOI: 10.1089/acm.2019.0321
  • Siti ZM, Tahir A, Farah AI, Fazlin SA, Sondi S, Azman AH, Maimunah AH, Haniza MA, Siti Haslinda MD, Zulkarnain AK, Zakiah I, Zaleha WW. Use of traditional and complementary medicine in Malaysia: A baseline study. Complement Ther Med. 2009;17(5-6):292-299. DOI: 10.1016/j.ctim.2009.04.002
  • de Moraes Mello Boccolini P, Siqueira Boccolini C. prevalence of complementary and alternative medicine (CAM) use in Brazil. BMC Complement Med Ther. 2020;20(1):1-10. DOI: 10.1186/s12906-020-2842-8
  • Metcalfe A, Williams J, McChesney J, Patten SB, Jetté N. use of complementary and alternative medicine by those with a chronic disease and the general population-Results of a national population based survey. BMC Complement Altern Med. 2010;10(1):1-6. DOI: 10.1186/1472-6882-10-58
  • Welz AN, Emberger Klein A, Menrad K. Why people use herbal medicine: Insights from a focus-group study in Germany. BMC Complement Altern Med. 2018;18(1):1-9. DOI: 10.1186/s12906-018-2160-6
  • Adib-Hajbaghery M, Hoseinian M. Knowledge, attitude and practice toward complementary and traditional medicine among Kashan Health Care Staff, 2012. Complement Ther Med. 2014;22(1):126-132. DOI: 10.1016/j.ctim.2013.11.009
  • Mwaka AD, Mangi SP, Okuku FM. Use of traditional and complementary medicines by cancer patients at a national cancer referral facility in a low‐income country. Eur J Cancer Care (Engl). 2019;28(6):e13158. DOI: 10.1111/ecc.13158
  • Pokladnikova J, Selke-Krulichova I. Prevalence of complementary and alternative medicine use in the general population in the Czech Republic. Forsch Komplementmed. 2016;23(1):22-28. DOI: 10.1159/000443712
  • Chingwaru W, Vidmar J. Prevalence, perceptions and factors influencing the use of traditional and complementary medicine (T&CM) in Zimbabwe’s adult population: The case of Bindura District. Eur J Integr Med. 2016;8(4):484-493. DOI: 10.1016/j.eujim.2016.03.007
  • Şimşek B, Aksoy DY, Basaran NC, Taş D, Albasan D, Kalaycı MZ. Mapping traditional and complementary medicine in Turkey. Eur J Integr Med. 2017;15:68-72. DOI: 10.1016/j.eujim.2017.09.006

Complementary and Alternative Medicine Uses of Individuals Diagnosed With Chronic Diseases

Year 2023, , 184 - 191, 28.03.2023
https://doi.org/10.33808/clinexphealthsci.1185236

Abstract

Objective: The aim of the study was to evaluate the use of CAM practices by individuals who have been admitted to health institutions and have been diagnosed with chronic diseases.
Methods: Patients with a diagnosis of chronic disease were included in this cross-sectional observational study. The use of 15 CAM modalities were evaluated in accordance with the Traditional and Complementary Medicine Regulations. Logistic regression analysis was further performed the association between CAM use and related factors.
Results: The mean age of 692 people in the study group was 50.6±13.6 years. In this study, the frequency of CAM use was found to be 37.1%. Univariate and age adjusted univariate logistic regression analysis performed to determine the correlation of the use of CAM practices with respect to sociodemographic variables and health-related variables revealed that being a woman, admitting to faculty of medicine, not having an income-generating job and living in an extended family were found to be positive predictors of CAM use.
Conclusion: The fact that one out of every three patients diagnosed with a chronic disease and who have admitted to a health care institution had already experienced CAM practices indicate that the orientation towards CAM practices is quite high. Further comprehensive research is necessary with regard to planning the integration of CAM practices into health services.

References

  • World Health Organization, Global Health Estimates, Leading Causes of Death and Disability, A Visual Summary of Global and Regional Trends 2000-2019. Accessed [19 March 2022]. https://www.who.int/data/stories/leading-causes-of-death-and-disability-2000-2019-a-visual-summary
  • The Lancet Infographics Global Burden of Disease 2019. Accessed [30 September 2021]. https://www.thelancet.com/infographics/gbd-2019
  • World Health Organization. Global Status Report on Noncommunicable Diseases 2014. Accessed [2 February 2020]. https://www.who.int/publications/i/item/9789241564854
  • World Health Organization. Traditional, Complementary and Integrative Medicine. Overview. Accessed [2 February 2020]. https://www.who.int/health-topics/traditional-complementary-and-integrative-medicine#tab=tab_1
  • World Health Organization. WHO Traditional Medicine Strategy: 2014-2023. Accessed [3 February 2020]. https://www.who.int/publications/i/item/9789241506096
  • Burton A, Smith M, Falkenberg T. Building WHO's Global strategy for traditional medicine. Eur J Integr Med. 2015;7(1):13-5. DOI: 10.1016/j.eujim.2014.12.007
  • Mevzuat Bilgi Sistemi. Geleneksel ve Tamamlayıcı Tıp Uygulamaları Yönetmeliği. Accessed [6 February 2020]. https://www.mevzuat.gov.tr/mevzuat?MevzuatNo=20164&MevzuatTur=7&MevzuatTertip=5
  • Ung COL, Harnett J, Hu H. Community pharmacist's responsibilities with regards to traditional medicine/complementary medicine products: A systematic literature review. Res Social Adm Pharm. 2017;13(4):686-716. DOI: 10.1016/j.sapharm.2016.08.001
  • Wode K, Henriksson R, Sharp L, Stoltenberg A, Hök Nordberg J. Cancer patients’ use of complementary and alternative medicine in Sweden: A cross-sectional study. BMC Complement Altern Med. 2019;19(1):1-11. DOI: 10.1186/s12906-019-2452-5
  • Foley H, Steel A, McIntyre E, Harnett J, Sibbritt D, Wardle J, Adams J. Complementary medicine practitioner consultations amongst 1,314 individuals with chronic conditions: Characteristics of users, reasons for and predictors of use. Complement Ther Clin Pract. 2020;40:101194. DOI: 10.1016/j.ctcp.2020.101194
  • Gyasi R, Buor D, Adu-Gyamfi S, Adjei PO-W, Amoah PA. Sociocultural hegemony, gendered identity, and use of traditional and complementary medicine in Ghana. Women Health 2018;58(5):598-615. DOI: 10.1080/03630242.2017.1321608
  • Türkiye İstatistik Kurumu, Adrese Dayalı Nüfus Kayıt Sistemi Sonuçları, Adrese Dayalı Nüfus Kayıt Sistemi İstatistikleri. Accessed [1 May 2020]. http://tuik.gov.tr/PreTablo.do?alt_id=1059
  • T.C. Sağlık Bakanlığı Eskişehir İl Sağlık Müdürlüğü, Aile Sağlığı Merkezleri, Hastaneler. Accessed [1 May 2020]. https://eskisehirism.saglik.gov.tr/TR,39889/aile-sagligi-merkezleri.html
  • Daye M, Durmaz K, Durduran Y. Traditional and complementary medicine practices in patients admitted to dermatology outpatient clinic. Konuralp Medical Journal 2020;12(2):247-252. DOI: 10.18521/ktd.639063
  • Yıldız P, Fatih Ü, Balbay EG. Kronik obstrüktif akciğer hastalarında geleneksel ve tamamlayıcı tıp yöntemi kullanımının değerlendirilmesi. Online Turkish Journal of Health Sciences 2020;5(1):147-54. DOI: 10.26453/otjhs.638683
  • T.C. Resmi Gazete, Sağlık Bakanlığı Geleneksel Ve Tamamlayıcı Tıp Uygulamaları Yönetmeliği. Accessed [16 August 2020]. https://www.resmigazete.gov.tr/eskiler/2014/10/20141027.pdf
  • Lam CS, Koon HK, Chung VCH, Cheung YT. A Public survey of traditional, complementary and integrative medicine use during the COVID-19 outbreak in Hong Kong. PloS One 2021;16(7): 1-15. DOI: 10.1371/journal.pone.0253890
  • Kearns K, Dee A, Fitzgerald AP, Doherty E, Perry IJ. Chronic disease burden associated with overweight and obesity in Ireland: The effects of a small BMI reduction at population level. BMC Public Health 2014;14(1):1-10. DOI: 10.1186/1471-2458-14-143
  • Shahjalal M, Chakma SK, Ahmed T, Yasmin I, Mahumud RA, Hossain A. Prevalence and determinants of using complementary and alternative medicine for the treatment of chronic illnesses: A multicenter study in Bangladesh. PLoS One 2022;17(1): 1-13 DOI: 10.1371/journal.pone.0262221.
  • Bhalerao MS, Bolshete PM, Swar BD, Bangera TA, Kolhe VR, Tambe MJ, Wade MP, Bhowate SD, Sonje UB, Gogtay NJ, Thatte UM. Use of and satisfaction with complementary and alternative medicine in four chronic diseases: A Cross-sectional study from India. Natl Med J India 2013;26(2):75-77.
  • Osamor PE, Owumi BE. Complementary and alternative medicine in the management of hypertension in an urban Nigerian community. BMC Complement Altern Med 2010;10(1):1-9. DOI: 10.1186/1472-6882-10-36
  • Ogbera AO, Dada O, Adeleye F, Jewo PI. Complementary and alternative medicine use in diabetes mellitus. West Afr J Med. 2010;29(3):158-162 DOI: 10.4314/wajm.v29i3.68213
  • Radwan H, Hasan H, Hamadeh R, Hashim M, AbdulWahid Z, Hassanzadeh Gerashi M, Al Hilali M, Naja F. Complementary and alternative medicine use among patients with type 2 diabetes living in the United Arab Emirates. BMC Complement Med Ther. 2020;20(1):216. DOI: 10.1186/s12906-020-03011-5.
  • Judson PL, Abdallah R, Xiong Y, Ebbert J, Lancaster JM. Complementary and alternative medicine use in individuals presenting for care at a comprehensive cancer center. Integr Cancer Ther. 2017;16(1):96-103. DOI: 10.1177/1534735416660384
  • Armstrong AR, Thiébaut SP, Brown LJ, Nepal B. Australian adults use complementary and alternative medicine in the treatment of chronic illness: A national study. Aust N Z J Public Health 2011;35(4):384-390. DOI: 10.1111/j.1753-6405.2011.00745.x
  • Raja R, Kumar V, Khan MA, Sayeed KA, Hussain SZM, Rizwan A. Knowledge, attitude, and practices of complementary and alternative medication usage in patients of type II diabetes mellitus. Cureus 2019;11(8):e5357 DOI: 10.7759/cureus.5357
  • Al-Eidi S, Tayel S, Al-Slail F, Qureshi NA, Sohaibani I, Khalil M, Al-Bedah AM. Knowledge, attitude, and practices of patients with type II diabetes mellitus towards complementary and alternative medicine. J Integr Med. 2016;14(3):187-196. DOI: 10.1016/S2095-4964(16)60244-3
  • Mollaoğlu M, Aciyurt A. Use of complementary and alternative medicine among Patients with Chronic Diseases. Acta Clin Croat. 2013;52(2.):181-188.
  • Hasan SS, Ahmed SI, Bukhari NI, Loon WCW. Use of complementary and alternative medicine among patients with chronic diseases at outpatient clinics. Complement Ther Clin Pract. 2009;15(3):152-157. DOI: 10.1016/j.ctcp.2009.02.003
  • Demirci GT, Altunay IK. Use of complementary and alternative medicine and assessment of dermatology quality of life index among dermatology outpatients: A cross-sectional comparative study. Br J Med Med Res. 2014;4(9):1812-1820 DOI: 10.9734/BJMMR/2014/6924
  • Ee C, Templeman K, Grant S, Avard N, de Manincor M, Reath J, Hunter J. Informing the model of care for an academic integrative health care center: A qualitative study of primary care stakeholder views. J Altern Complement Med. 2020;26(4):300-315. DOI: 10.1089/acm.2019.0321
  • Siti ZM, Tahir A, Farah AI, Fazlin SA, Sondi S, Azman AH, Maimunah AH, Haniza MA, Siti Haslinda MD, Zulkarnain AK, Zakiah I, Zaleha WW. Use of traditional and complementary medicine in Malaysia: A baseline study. Complement Ther Med. 2009;17(5-6):292-299. DOI: 10.1016/j.ctim.2009.04.002
  • de Moraes Mello Boccolini P, Siqueira Boccolini C. prevalence of complementary and alternative medicine (CAM) use in Brazil. BMC Complement Med Ther. 2020;20(1):1-10. DOI: 10.1186/s12906-020-2842-8
  • Metcalfe A, Williams J, McChesney J, Patten SB, Jetté N. use of complementary and alternative medicine by those with a chronic disease and the general population-Results of a national population based survey. BMC Complement Altern Med. 2010;10(1):1-6. DOI: 10.1186/1472-6882-10-58
  • Welz AN, Emberger Klein A, Menrad K. Why people use herbal medicine: Insights from a focus-group study in Germany. BMC Complement Altern Med. 2018;18(1):1-9. DOI: 10.1186/s12906-018-2160-6
  • Adib-Hajbaghery M, Hoseinian M. Knowledge, attitude and practice toward complementary and traditional medicine among Kashan Health Care Staff, 2012. Complement Ther Med. 2014;22(1):126-132. DOI: 10.1016/j.ctim.2013.11.009
  • Mwaka AD, Mangi SP, Okuku FM. Use of traditional and complementary medicines by cancer patients at a national cancer referral facility in a low‐income country. Eur J Cancer Care (Engl). 2019;28(6):e13158. DOI: 10.1111/ecc.13158
  • Pokladnikova J, Selke-Krulichova I. Prevalence of complementary and alternative medicine use in the general population in the Czech Republic. Forsch Komplementmed. 2016;23(1):22-28. DOI: 10.1159/000443712
  • Chingwaru W, Vidmar J. Prevalence, perceptions and factors influencing the use of traditional and complementary medicine (T&CM) in Zimbabwe’s adult population: The case of Bindura District. Eur J Integr Med. 2016;8(4):484-493. DOI: 10.1016/j.eujim.2016.03.007
  • Şimşek B, Aksoy DY, Basaran NC, Taş D, Albasan D, Kalaycı MZ. Mapping traditional and complementary medicine in Turkey. Eur J Integr Med. 2017;15:68-72. DOI: 10.1016/j.eujim.2017.09.006
There are 40 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Articles
Authors

Didem Oktar 0000-0002-7345-0331

Selma Metintas 0000-0002-5002-5041

Muhammed Fatih Önsüz 0000-0001-7234-3385

Ece Elif Öcal 0000-0001-8977-6478

Seval Çalışkan Pala 0000-0002-9815-8425

Publication Date March 28, 2023
Submission Date October 6, 2022
Published in Issue Year 2023

Cite

APA Oktar, D., Metintas, S., Önsüz, M. F., Öcal, E. E., et al. (2023). Complementary and Alternative Medicine Uses of Individuals Diagnosed With Chronic Diseases. Clinical and Experimental Health Sciences, 13(1), 184-191. https://doi.org/10.33808/clinexphealthsci.1185236
AMA Oktar D, Metintas S, Önsüz MF, Öcal EE, Çalışkan Pala S. Complementary and Alternative Medicine Uses of Individuals Diagnosed With Chronic Diseases. Clinical and Experimental Health Sciences. March 2023;13(1):184-191. doi:10.33808/clinexphealthsci.1185236
Chicago Oktar, Didem, Selma Metintas, Muhammed Fatih Önsüz, Ece Elif Öcal, and Seval Çalışkan Pala. “Complementary and Alternative Medicine Uses of Individuals Diagnosed With Chronic Diseases”. Clinical and Experimental Health Sciences 13, no. 1 (March 2023): 184-91. https://doi.org/10.33808/clinexphealthsci.1185236.
EndNote Oktar D, Metintas S, Önsüz MF, Öcal EE, Çalışkan Pala S (March 1, 2023) Complementary and Alternative Medicine Uses of Individuals Diagnosed With Chronic Diseases. Clinical and Experimental Health Sciences 13 1 184–191.
IEEE D. Oktar, S. Metintas, M. F. Önsüz, E. E. Öcal, and S. Çalışkan Pala, “Complementary and Alternative Medicine Uses of Individuals Diagnosed With Chronic Diseases”, Clinical and Experimental Health Sciences, vol. 13, no. 1, pp. 184–191, 2023, doi: 10.33808/clinexphealthsci.1185236.
ISNAD Oktar, Didem et al. “Complementary and Alternative Medicine Uses of Individuals Diagnosed With Chronic Diseases”. Clinical and Experimental Health Sciences 13/1 (March 2023), 184-191. https://doi.org/10.33808/clinexphealthsci.1185236.
JAMA Oktar D, Metintas S, Önsüz MF, Öcal EE, Çalışkan Pala S. Complementary and Alternative Medicine Uses of Individuals Diagnosed With Chronic Diseases. Clinical and Experimental Health Sciences. 2023;13:184–191.
MLA Oktar, Didem et al. “Complementary and Alternative Medicine Uses of Individuals Diagnosed With Chronic Diseases”. Clinical and Experimental Health Sciences, vol. 13, no. 1, 2023, pp. 184-91, doi:10.33808/clinexphealthsci.1185236.
Vancouver Oktar D, Metintas S, Önsüz MF, Öcal EE, Çalışkan Pala S. Complementary and Alternative Medicine Uses of Individuals Diagnosed With Chronic Diseases. Clinical and Experimental Health Sciences. 2023;13(1):184-91.

14639   14640